Biotech Analysts See Return to Normal After Virus-Driven Frenzy

(Bloomberg) -- The rush of investors seeking a crash course in drug development and biology has waned even amid a rising number of coronavirus infections, and Wall Street biotechnology analysts and...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.